Language
Grade: Pharmaceutical Grade
Factory Location: Shandong
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
|
Dexlansoprazole with CAS 138530-94-6 is a proton pump inhibitor that is marketed by Takeda Pharmaceuticals. Dexlansoprazole (CAS 138530-94-6), Chemically, is an enantiomer of lansoprazole. The compound was launched in the US for use in the treatment and maintenance of patients with erosive oesophagitis and non-erosive gastro-oesophageal reflux disease (GERD or GORD). |
The product above are not for sales where the patents are applicable and still valid.